Larvol Delta - Alector-Announces-Completion-of-Enrollment-in-the-PROGRESSAD-Phase-2-Clinical-Trial-of-AL101GSK4527226-in-Individuals-with-Early-Alzheimers-Disease

GSK4527226 - Alector, GSK

https://www.globenewswire.com/news-release/2025/04/17/3063333/0/en/Alector-Announces-Completion-of-Enrollment-in-the-PROGRESS-AD-Phase-2-Clinical-Trial-of-AL101-GSK4527226-in-Individuals-with-Early-Alzheimer-s-Disease.html

Apr 17, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next